Literature DB >> 7822457

A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes.

B van Gemen1, R van Beuningen, A Nabbe, D van Strijp, S Jurriaans, P Lens, T Kievits.   

Abstract

Quantification of HIV-1 viral RNA based on co-amplification of an internal standard Q-RNA dilution series requires a number of NASBA nucleic acid amplification reactions. For each internal standard Q-RNA concentration a separate NASBA amplification has to be performed. The development of an electrochemiluminescent (ECL) detection system with a dynamic signal detection range over 5 orders of magnitude enabled simplification of the Q-NASBA protocol. Three distinguishable Q-RNAs (QA, QB and QC) are mixed with the wild-type sample at different amounts (i.e. 10(4) QA, 10(3) QB and 10(2) QC molecules) and co-amplified with the wild-type RNA in one tube. Using ECL-labelled oligonucleotides the wild-type, QA, QB and QC amplificates are separately detected with a semi-automated ECL detection instrument and the ratio of the signals determined. The amount of initial wild-type RNA can be calculated from the ratio of wild-type signal to QA, QB and QC signals. This one-tube Q-NASBA protocol was compared to the earlier described protocol with six amplifications per quantification using model systems and HIV-1 RNA isolated from plasma of HIV-1-infected individuals. In all cases the quantification results of HIV-1 RNA were comparable between the two methods tested. Due to the use of only one amplification per quantification in the one-tube Q-NASBA protocol the QA, QB and QC internal standard RNA molecules can be added to the sample before nucleic acid isolation. The ratio of QA:QB:QC:WT RNAs, from which the initial input of WT-RNA is calculated, will remain constant independent of any loss that might occur during the nucleic acid isolation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7822457     DOI: 10.1016/0166-0934(94)90040-x

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  57 in total

1.  Comparison of levels of human immunodeficiency virus type 1 RNA in plasma as measured by the NucliSens nucleic acid sequence-based amplification and Quantiplex branched-DNA assays.

Authors:  C C Ginocchio; S Tetali; D Washburn; F Zhang; M H Kaplan
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

2.  Principles of quantitation of viral loads using nucleic acid sequence-based amplification in combination with homogeneous detection using molecular beacons.

Authors:  Jos J A M Weusten; Wim M Carpay; Tom A M Oosterlaken; Martien C A van Zuijlen; Paul A van de Wiel
Journal:  Nucleic Acids Res       Date:  2002-03-15       Impact factor: 16.971

Review 3.  Characteristics and applications of nucleic acid sequence-based amplification (NASBA).

Authors:  Birgit Deiman; Pierre van Aarle; Peter Sillekens
Journal:  Mol Biotechnol       Date:  2002-02       Impact factor: 2.695

4.  Improved detection of rhinoviruses by nucleic acid sequence-based amplification after nucleotide sequence determination of the 5' noncoding regions of additional rhinovirus strains.

Authors:  K Loens; M Ieven; D Ursi; C De Laat; P Sillekens; P Oudshoorn; H Goossens
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

5.  Rapid enterovirus RNA detection in clinical specimens by using nucleic acid sequence-based amplification.

Authors:  Marie L Landry; Robin Garner; David Ferguson
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

6.  Stochastic processes defining sensitivity and variability of internally calibrated quantitative NASBA-based viral load assays.

Authors:  Jos J A M Weusten; Pieter A W M Wouters; Martien C A van Zuijlen; Paul A van de Wiel
Journal:  Nucleic Acids Res       Date:  2002-12-15       Impact factor: 16.971

7.  Quantitative nucleic acid sequence-based assay as a new molecular tool for detection and quantification of Leishmania parasites in skin biopsy samples.

Authors:  Wendy F van der Meide; Gerard J Schoone; William R Faber; Jim E Zeegelaar; Henry J C de Vries; Yusuf Ozbel; Rudy F M Lai A Fat; Leíla I A R C Coelho; Masoom Kassi; Henk D F H Schallig
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

8.  One-tube real-time isothermal amplification assay to identify and distinguish human immunodeficiency virus type 1 subtypes A, B, and C and circulating recombinant forms AE and AG.

Authors:  M P de Baar; E C Timmermans; M Bakker; E de Rooij; B van Gemen; J Goudsmit
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

9.  Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load.

Authors:  Leondios G Kostrikis; Giota Touloumi; Rose Karanicolas; Nikos Pantazis; Cleo Anastassopoulou; Anastasia Karafoulidou; James J Goedert; Angelos Hatzakis
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Human immunodeficiency virus type 1 bound to B cells: relationship to virus replicating in CD4+ T cells and circulating in plasma.

Authors:  Angela Malaspina; Susan Moir; David C Nickle; Eileen T Donoghue; Kisani M Ogwaro; Linda A Ehler; Shuying Liu; Jo Ann M Mican; Mark Dybul; Tae-Wook Chun; James I Mullins; Anthony S Fauci
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.